Biblio
] , “White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251316516, 2025.
, “Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ 40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 93, no. 1, pp. 333-348, 2023.
, “A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.”, J Alzheimers Dis, vol. 73, no. 1, pp. 217-227, 2020.
